Biomarker-directed Targeted Therapy Plus Durvalumab in Advanced Non-Small-cell Lung Cancer: a Phase 2 Umbrella Trial
Benjamin Besse,Elvire Pons-Tostivint,Keunchil Park,Sylvia Hartl,Patrick M. Forde,Maximilian J. Hochmair,Mark M. Awad,Michael Thomas,Glenwood Goss,Paul Wheatley-Price,Frances A. Shepherd,Marie Florescu,Parneet Cheema,Quincy S. C. Chu,Sang-We Kim,Daniel Morgensztern,Melissa L. Johnson,Sophie Cousin,Dong-Wan Kim,Mor T. Moskovitz,David Vicente, Boaz Aronson,Rosalind Hobson,Helen J. Ambrose,Sajan Khosla,Avinash Reddy,Deanna L. Russell,Mohamed Reda Keddar, James P. Conway,J. Carl Barrett,Emma Dean,Rakesh Kumar, Marlene Dressman,Philip J. Jewsbury,Sonia Iyer,Simon T. Barry,Jan Cosaert,John V. Heymach Nature Medicine（2024）
Key words
Biomarkers for Immunotherapy,Cancer Therapy,Biomarker Analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper